Stock Message Boards
ETF Channel
Market News Video Self Directed Investor The Warren Buffetts Next Door Stock message boards Portfolio Channel


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

PFE Description — Pfizer Inc

Pfizer is a research-based biopharmaceutical company. Co.'s Primary Care segment includes products prescribed by primary-care physicians. Co.'s Specialty Care and Oncology segment includes products prescribed by physicians who are specialists. Co.'s Established Products and Emerging Markets segment includes products that have lost patent protection or marketing rights and those sold in emerging markets. Co.'s Animal Health segment includes products and services to address disease in livestock and companion animals. Co.'s Consumer Healthcare segment includes non-prescription products in several therapeutic categories.

Company Name:  Pfizer Inc
Website:  www.pfizer.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding PFE:  96
Total Market Value Held by ETFs:  $7,311,893,506
Total Market Capitalization:  $190,658,000,000
% of Market Cap. Held by ETFs:  3.84%
 ETF   PFE Weight   PFE Amount 
 SPY   1.19%   $1,886,669,505         
 XLV   8.79%   $870,258,785         
 IVV   1.17%   $631,468,954         
 IWD   2.14%   $452,460,280         
 VTI   1.03%   $421,250,945         
 VYM   2.60%   $278,704,057         
 VTV   2.09%   $269,760,264         
 VHT   7.55%   $244,648,074         
 IYH   8.34%   $222,622,700         
 VOO   1.23%   $207,637,807         
List of all 96 ETFs holding PFE »
10 ETFs With Stocks That Insiders Are Buying
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs
The Top 10 DividendRank'ed Stocks
The DividendRank Top 25
The Top 10 DividendRank'ed DJIA Components
The Top 10 DividendRank'ed Dow Transports Components
The Top 10 DividendRank'ed Dow Utilities Components
The Top 10 DividendRank'ed Nasdaq 100 Components
10 Stocks Going Ex-Dividend
10 Oversold Dividend Stocks
10 Stocks Where Yields Got More Juicy
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Top Ranked Dividend Stocks With Insider Buying
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Metals Stocks You Can Buy Cheaper Than Insiders Did
10 Oversold Metals Stocks
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Oversold Energy Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
10 Stocks Crossing Below Book Value
10 Stocks Crossing Above Their 200 Day Moving Average
10 Stocks Crossing Below Their 200 Day Moving Average
10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
The Top 10 DividendRank'ed Canadian Stocks
The DividendRank Canada Top 25
10 Canadian Stocks Going Ex-Dividend
10 Oversold Canadian Stocks
10 Canadian Stocks Where Yields Got More Juicy
10 Must-Know High-Yield Canadian Real Estate Stocks
10 Top DividendRank'ed Canadian Financials
10 Must-Know High-Yield Canadian Energy Stocks
10 Canadian Stocks Crossing Below Book Value
10 Canadian Stocks Crossing Above Their 200 Day Moving Avg
10 Canadian Stocks Crossing Below Their 200 Day Moving Avg
Stock market game
Quotes delayed 20 minutes

Trade PFE Now:



Buy (3.14 out of 4)
59th percentile
(ranked higher than approx. 59% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Portfolio Channel

PARTNER NEWS:

Tue, Apr 15, 2:30 PM, Zacks
Portola's Betrixaban Study Design Published - Analyst Blog
Portola announced the publication of the design and rationale of the phase III APEX study on betrixaban.

Mon, Apr 14, 8:30 AM, StreetAuthority
Hedge Funds Love These 3 Pharma Stocks

In 2012, the star performer among sectors was the financial sector. In 2013, it was consumer discretionary stocks. For 2014, which sector can we expect to top the list?

While

ETFs Holding PFE | Pfizer Inc | ETF Channel | www.ETFChannel.com | Copyright © 2009 - 2014, All Rights Reserved

Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.